Clinical Trials on LTBI - Latent Tuberculosis Infection in Russian Federation
Total 27 results
-
Tatyana ZubkovaCompletedTuberculosis InfectionRussian Federation
-
SPP Pharmaclon Ltd.RecruitingPulmonary TuberculosisRussian Federation
-
Research and Practical Clinical Center for Diagnostics...Active, not recruitingTuberculosis, PulmonaryRussian Federation
-
SanofiCompletedTuberculosis, PulmonaryRussian Federation
-
National Medical Research Center of Phthisiopulmonology...CompletedTuberculosisRussian Federation
-
Gamaleya Research Institute of Epidemiology and...CompletedTuberculosisRussian Federation
-
Gamaleya Research Institute of Epidemiology and...contract research organization Cromos Pharma; contract research organization...CompletedHealthyRussian Federation
-
Central Institute of Epidemiology, Moscow, RussiaMerck Sharp & Dohme LLCUnknownHIV Infections | TuberculosisRussian Federation
-
St. Petersburg Research Institute of Vaccines and...CompletedTolerability and Reactogenicity Trial of the Recombinant Tuberculosis Allergen in Healthy VolunteersTuberculosis | Skin TestsRussian Federation
-
Janssen Infectious Diseases BVBAApproved for marketingEarly Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary TuberculosisTuberculosisRussian Federation, Lithuania
-
SPP Pharmaclon Ltd.North-Western State Medical University named after I.I.MechnikovCompletedRNA Virus Infections | Lentivirus Infections | Tuberculosis, Pulmonary | Human Immunodeficiency Virus | HIV Coinfection | Aids/Hiv ProblemRussian Federation
-
University of VirginiaUnknown
-
Gamaleya Research Institute of Epidemiology and...RecruitingTuberculosisRussian Federation
-
Janssen Research & Development, LLCRecruitingMultidrug-Resistant TuberculosisMozambique, Philippines, Russian Federation, South Africa, Uganda, Ukraine
-
University of VirginiaNational Institute on Drug Abuse (NIDA); Scientific Center for Family Health...CompletedHIV Infections | Tuberculosis | Substance UseRussian Federation
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Extensively Drug-Resistant Tuberculosis | Tuberculosis, MDR | XDR-TB | Pre-XDR-TBSouth Africa, Russian Federation, Georgia, Moldova, Republic of
-
Brigham and Women's HospitalHarvard School of Public Health (HSPH); Mclean HospitalCompletedTuberculosis | Alcohol Use DisordersRussian Federation
-
Ilya SivokozovRecruitingPneumonia | Lung Cancer | TuberculosisRussian Federation
-
Ryazan State Medical UniversityActive, not recruitingMyocardial Infarction | Adherence, PatientRussian Federation
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Tuberculosis, MDR | Drug-Resistant TuberculosisTanzania, Georgia, Russian Federation, Brazil, Malaysia, Philippines, South Africa, Uganda
-
Janssen Infectious Diseases BVBACompletedTuberculosisChina, Ukraine, Korea, Republic of, Peru, Estonia, Kenya, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey
-
SPP Pharmaclon Ltd.RecruitingRespiratory TuberculosisRussian Federation
-
Janssen Infectious Diseases BVBAWithdrawnMulti-drug Resistant TuberculosisChina, Ukraine, Taiwan, Korea, Republic of, Peru, Brazil, Estonia, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey, Georgia, Mexico, Cambodia, Ethiopia
-
Hepatera Ltd.CompletedChronic Viral Hepatitis B With Delta-agentRussian Federation
-
Janssen Infectious Diseases BVBACompletedTuberculosisSouth Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusMexico, Peru, Thailand, South Africa, Russian Federation, Argentina, Brazil
-
PfizerCompletedPneumococcal Disease | 13-valent Pneumococcal VaccineUnited States